CVI welcomes Matthew Whitlock, MD, and Erik Ingelsson, PhD
Matthew Whitlock, MD
Clinical Assistant Professor of Medicine, Cardiovascular Medicine
Dr. Whitlock received a BS in biomedical engineering from Duke University. Upon graduation, he worked as an engineer for a year at Pacesetter (now St. Jude) in Los Angeles before completing his MD at UNC-Chapel Hill in 2005. He completed his internal medicine residency training at Oregon Health & Science University and cardiology training at Vanderbilt in Nashville. He worked in California for a few years upon completing his cardiology training and returned to North Carolina to obtain training in advanced cardiovascular imaging (cardiac CT and MR) and a master's degree at Wake Forest University. At Stanford, he will have a split general cardiology position between the Monterey clinic and the VA Palo Alto Health Care System where he will work with the cardiovascular imaging program. His wife is on faculty in the Oncology department at Stanford. They both enjoy hiking, camping, and eating at "Roadfood" restaurants.
Dr. Ingelsson obtained his MD (2000) and PhD (2005) at Uppsala University, Sweden. After internship, he did a residency in general medicine (2003-2006) and took up a postdoctoral research fellowship at the Framingham Heart Study (2006-2007). He moved to Karolinska Institutet (Stockholm, Sweden) in 2007 and was appointed Professor of Cardiovascular Epidemiology in 2010. Since 2013, he has been Professor of Molecular Epidemiology at Uppsala University. He was also a Visiting Professor at the Wellcome Trust Centre for Human Genetics at University of Oxford in 2012-2015.
Dr. Ingelsson's main area of interest is the link between metabolic disturbances, such as obesity and insulin resistance, and the development of subclinical and clinical cardiovascular disease. His research is translational and interdisciplinary, combining methods from the molecular epidemiology field - such as genomic, metabolomic, transcriptomic, epigenomic and proteomic profiling in large population-based studies - with in vivo and in vitro work to reach new insights into the pathophysiology of cardiovascular disease and related conditions, identification of new biomarkers for improved risk prediction, and discovery of novel targets for drug development.
Dr. Ingelsson has published >220 original research papers, and been awarded a number of prestigious awards and prizes, the latest being the Göran Gustafsson Prize in Medicine 2015 (awarded by the Royal Swedish Academy of Sciences to the best medical researcher in Sweden below age 45). On his spare time, he likes to spend time with his family (wife Maria, Hugo, 12 and Alice, 10 years old) and friends; enjoys cooking, but also eating nice food and wine; tries to make his daily running routine; and sings in choirs - amongst others, the San Francisco Symphony Chorus.